617 related articles for article (PubMed ID: 31809283)
1. Microbiome and hypertension: where are we now?
Vallianou NG; Geladari E; Kounatidis D
J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):83-88. PubMed ID: 31809283
[TBL] [Abstract][Full Text] [Related]
2. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
[TBL] [Abstract][Full Text] [Related]
3. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
[TBL] [Abstract][Full Text] [Related]
4. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
5. Dietary metabolism, the gut microbiome, and heart failure.
Tang WHW; Li DY; Hazen SL
Nat Rev Cardiol; 2019 Mar; 16(3):137-154. PubMed ID: 30410105
[TBL] [Abstract][Full Text] [Related]
6. A cross-talk between gut microbiome, salt and hypertension.
Naqvi S; Asar TO; Kumar V; Al-Abbasi FA; Alhayyani S; Kamal MA; Anwar F
Biomed Pharmacother; 2021 Feb; 134():111156. PubMed ID: 33401080
[TBL] [Abstract][Full Text] [Related]
7. Curcumin ameliorates hypertension via gut-brain communication in spontaneously hypertensive rat.
Li HB; Xu ML; Du MM; Yu XJ; Bai J; Xia WJ; Dai ZM; Li CX; Li Y; Su Q; Wang XM; Dong YY; Kang YM
Toxicol Appl Pharmacol; 2021 Oct; 429():115701. PubMed ID: 34453990
[TBL] [Abstract][Full Text] [Related]
8. Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder.
Wang Y; Li N; Yang JJ; Zhao DM; Chen B; Zhang GQ; Chen S; Cao RF; Yu H; Zhao CY; Zhao L; Ge YS; Liu Y; Zhang LH; Hu W; Zhang L; Gai ZT
Pharmacol Res; 2020 Jul; 157():104784. PubMed ID: 32305492
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mediated remodeling of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rats.
Robles-Vera I; de la Visitación N; Toral M; Sánchez M; Gómez-Guzmán M; Jiménez R; Romero M; Duarte J
Biomed Pharmacother; 2021 Mar; 135():111189. PubMed ID: 33388596
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
12. Microbiota issue in CKD: how promising are gut-targeted approaches?
Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
[TBL] [Abstract][Full Text] [Related]
13. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
14. Microbiota and Hypertension: Role of the Sympathetic Nervous System and the Immune System.
Robles-Vera I; Toral M; Duarte J
Am J Hypertens; 2020 Oct; 33(10):890-901. PubMed ID: 32614942
[TBL] [Abstract][Full Text] [Related]
15. The gut microbiota and blood pressure in experimental models.
Jama HA; Kaye DM; Marques FZ
Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):97-104. PubMed ID: 30531472
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota: Potential for a Unifying Hypothesis for Prevention and Treatment of Hypertension.
Qi Y; Kim S; Richards EM; Raizada MK; Pepine CJ
Circ Res; 2017 May; 120(11):1724-1726. PubMed ID: 28546357
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota in kidney disease and hypertension.
Antza C; Stabouli S; Kotsis V
Pharmacol Res; 2018 Apr; 130():198-203. PubMed ID: 29496593
[TBL] [Abstract][Full Text] [Related]
18. Microglial Cells Impact Gut Microbiota and Gut Pathology in Angiotensin II-Induced Hypertension.
Sharma RK; Yang T; Oliveira AC; Lobaton GO; Aquino V; Kim S; Richards EM; Pepine CJ; Sumners C; Raizada MK
Circ Res; 2019 Mar; 124(5):727-736. PubMed ID: 30612527
[TBL] [Abstract][Full Text] [Related]
19. The role of the microbiome for human health: from basic science to clinical applications.
Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
[TBL] [Abstract][Full Text] [Related]
20. The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development.
Li J; Yang X; Zhou X; Cai J
Antioxid Redox Signal; 2021 Apr; 34(10):811-830. PubMed ID: 32316741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
